Fucoidan Rescues p-Cresol-Induced Cellular Senescence in Mesenchymal Stem Cells via FAK-Akt-TWIST Axis.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

30 citing papers in PubMed, 42 citations in OpenAlex.

1. Sustainable Discovery of Natural Anti-Aging Bioactives from Food Resources: Current Status and Machine Learning Perspectives.Current issues in molecular biology · 2026
   Review
2. SMP30: a promising cancer biomarker with therapeutic potential.Open medicine (Warsaw, Poland) · 2026
   Review
3. Fucoidan-based Nanomedicine for Hearing Loss: Emerging Roles as Carrier and Therapeutic Agent.Pharmaceutical research · 2025
   Review
4. The role of NADnpj metabolic health and disease · 2025
   Review
5. Preventing MSC aging and enhancing immunomodulation: Novel strategies for cell-based therapies.Regenerative therapy · 2025
   Review
6. Antiphotoaging effects of solvent fractions isolated fromBiochemistry and biophysics reports · 2024
   Article
7. Anti-Aging Activity and Modes of Action of Compounds from Natural Food Sources.Biomolecules · 2023
   Review
8. Effects of p-cresol, a uremic toxin, on cancer cells.Translational cancer research · 2023
   Article
9. Cellular senescence in brain aging and cognitive decline.Frontiers in aging neuroscience · 2023
   Review
10. Aging of mesenchymal stem cell: machinery, markers, and strategies of fighting.Cellular & molecular biology letters · 2022
    Review
11. High glucose mediates apoptosis and osteogenesis of MSCs via downregulation of AKT-Sirt1-TWIST.Molecular biology reports · 2022
    Article
12. The molecular mechanisms and intervention strategies of mitophagy in cardiorenal syndrome.Frontiers in physiology · 2022
    Review
13. Melatonin Protects Chronic Kidney Disease Mesenchymal Stem/Stromal Cells against Accumulation of Methylglyoxal via Modulation of Hexokinase-2 Expression.Biomolecules & therapeutics · 2022
    Article
14. Diabetic Kidney Disease Alters the Transcriptome and Function of Human Adipose-Derived Mesenchymal Stromal Cells but Maintains Immunomodulatory and Paracrine Activities Important for Renal Repair.Diabetes · 2021
    Article
15. Uremic Toxins and Frailty in Patients with Chronic Kidney Disease: A Molecular Insight.International journal of molecular sciences · 2021
    Review
16. Natural Products in the Prevention of Metabolic Diseases: Lessons Learned from the 20th KAST Frontier Scientists Workshop.Nutrients · 2021
    Review
17. Potential Anti-Aging Substances Derived from Seaweeds.Marine drugs · 2020
    Review
18. Senescent mesenchymal stem/stromal cells and restoring their cellular functions.World journal of stem cells · 2020
    Review
19. Effects ofInternational journal of molecular sciences · 2020
    Article
20. CCR3 antagonist protects against induced cellular senescence and promotes rejuvenation in periodontal ligament cells for stimulating pulp regeneration in the aged dog.Scientific reports · 2020
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

4 authors at 3 institutions in 2 countries.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as